Loading resource…

Lindsay M. Forbes, MD; William K. Cornwell, MD, MSCS
Since the 1990s, the landscape of pulmonary arterial hypertension (PAH) has changed significantly, with an increase in older patients and those with comorbidities. This editorial evaluates a study that characterizes patients with PAH and elevated PAWP, challenging traditional definitions and highlighting the complexity of PAH phenotypes. It emphasizes the need for nuanced understanding in treatment approaches, particularly as some patients may not respond favorably to standard therapies. The editorial also discusses the limitations of current categorization strategies and the importance of high-quality data in guiding clinical practice.
No account needed